| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Multiple sclerosis | 160 | 68 | |
| Improve mobility | 27 | 8 | |
| Stiffness/spasticity | 22 | 10 | |
| Pain | 13 | 8 | |
| Optic nerve inflammation (optic neuritis) | 8 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Metallic taste in mouth | 33 | |
| Weight gain | 26 | |
| Facial flushing | 24 | |
| Flushing | 24 | |
| Feeling hot/overheating | 23 | |
| Fatigue | 17 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 24 | |
| Moderate | 60 | |
| Mild | 54 | |
| None | 20 |
Member evaluations
Aturo
evaluated on Nov 21, 2011
- Perceived effectiveness for pain: Slight
- Side effects: Mild
jmartell
evaluated on Sep 01, 2010
- Perceived effectiveness for relapse MS (exacerbation): None
- Side effects: None
tiredand sick
evaluated on Aug 26, 2010
- Perceived effectiveness for multiple sclerosis: Moderate
- Side effects: Moderate